Related Experiment Video
Updated: Apr 27, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9
Saima M Sidik1, Caroline G Hackett1, Fanny Tran2
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America.
Abstract:
Toxoplasma gondii is a parasite of humans and animals, and a model for other apicomplexans including Plasmodium spp., the causative agents of malaria. Despite many advances, manipulating the T. gondii genome remains labor intensive, and is often restricted to lab-adapted strains or lines carrying mutations that enable selection. Here, we use the RNA-guided Cas9 nuclease to efficiently generate knockouts without selection, and to introduce point mutations and epitope tags into the T. gondii genome. These methods will streamline the functional analysis of parasite genes and enable high-throughput engineering of their genomes.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR

